You searched for "students"

1372 results found

Can diuretics increase the risk of acute angle closure glaucoma?

Diuretics, used widely in the treatment of hypertension, oedema, heart failure and liver failure, have been implicated in case reports in scientific literature to be linked to bilateral acute angle closure glaucoma (AACG). The aim of this study was to...

Primary visual pathway changes in individuals with chronic mild traumatic brain injury

Patients with mild traumatic brain injury (mTBI) often self-report vision disturbance despite showing no reduction of visual acuity or fundus examination abnormality. This prospective, observational, cross-sectional study aimed to determine if using a sweeping array of investigations can help diagnose...

EDOF intraocular lens in eyes with preexisting retinal disease

Extended depth of focus (EDOF) intraocular lens (IOL) offers improved near and intermediate vision, aiming to reduce spectacle dependence in cataract patients. This study aims to evaluate the performance of EDOF lenses following cataract surgery in patients with retinal pathology....

Results of vitrectomy in epiretinal membranes secondary to retinal vein occlusions

This retrospective, observational multicentre study investigated the anatomic and functional results of vitrectomy associated with the peeling of secondary epiretinal membranes (ERM) in patients with retinal vein occlusion (RVO) and determined the prognostic factors of surgical outcomes. Data was collected...

Scope Ophthalmology announce case awards winners

Scope Eyecare are delighted to announce the winners of the Scope Ophthalmology case awards UK and Ireland for 2023.

Vabysmo receives NICE approval

The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...

SCOPE Announces 2025 Independent Prescriber Bursary Award Winners

SCOPE is proud to announce the winners of its 2025 Independent Prescriber (IP) Bursary Awards, an initiative now in its fourth year. Designed to support optometrists in gaining IP qualifications by covering course fees, the awards continue to attract strong...

The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...

Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report

Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...

RANZCO Congress 2025

The Royal Australian and New Zealand College of Ophthalmologists Annual Congress 2025

Everyday diabetes medicine could treat common cause of blindness

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

Comparison of the efficacy of anti-VEGFs agents in nvAMD

This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...